TCTC for Head and Neck Cancer & Esophageal Cancer
In Taiwan, the reimbursement for chemotherapy drugs to treat head and neck cancer, or esophageal cancer is very limited. Therefore, most of the oncologists and surgical oncologists treated patients by jointing the international clinical trials or PI initiated clinical trial. Our previous experience in clinical trials demonstrated we were well qualified and received recognition by international pharmaceutical company. To facilitate performing good quality clinical trials in Taiwan, we plan to establish Head and neck cancer and esophageal cancer consortium.
1. Head and neck cancer
2. Esophageal cancer
1. To organize and establish the Taiwan Head and Neck cancer and Esophageal cancer consortium group to collect clinical data and tissue specimen.
2. To help domestic company to perform clinical trial for generic drugs.
3. To facilitate PI initiated clinical trials
4. To help domestic company develop novel drugs and translation to clinical trials.
5. To join more international clinical trials and complete the trials in time in this consortium.
Department of Oncology, Taipei Veterans General Hospital
Department of Oncology, Taipei Veterans General Hospital
Department of Oncology, Taipei Veterans General Hospital
Department of Oncology, Taipei Veterans General Hospital
Department of Oncology, Taipei Veterans General Hospital
Department of Oncology, Taipei Veterans General Hospital
Division of Hematology & Oncology, China Medical University Hospital
Division of Hematology & Oncology, China Medical University Hospital
Division of Hematology & Oncology, China Medical University Hospital
Department of Oncology, National Chung Kung University Hospital
Division of Gastroenterology, Kaohsiung Medical University Hospital
Division of Hematology & Oncology, Kaohsiung Medical University Hospital
Contact Information
c-IRB